4 December, 2025

A blood test holds the key to tailored therapies for severe asthma

We share this report on the recent discovery by the Precision Medicine in Respiratory Diseases (PRES) group, a new method to improve the effectiveness of treatments for this pathology.
November 24, 2025

Researchers from Aragon discover key biomarkers that improve the diagnosis and treatment of severe asthma

The Precision Medicine in Respiratory Diseases (PRES) group at IIS Aragón has identified new molecules present in blood and sputum that allow for precise distinction between the two major subtypes of severe asthma.